Studies different diagnostic and treatment approaches for thyroid conditions in adults
Observes adults with thyroid disorders, including nodules, hyperthyroidism, hypothyroidism and thyroid cancer.
Key facts
- Who runs it
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Where
- Bologna, ItalySee the site
- Trial code
- Registry title
- Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
- Status
- Recruiting
- People taking part
- 5,850 people, planned
- Started
- 30 Dec 2021
- Expected to end
- 30 Dec 2041
- Type of study
- Observational, 2 groups
- Record updated
- 17 January 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a thyroid problem: underactive or overactive thyroid, a benign thyroid nodule, or thyroid cancer.
- Age
- Older than 18 years at the time of diagnosis (minimum age 18 years).
- Sex
- All sexes can join.
- Disease stage
- Hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodule, or thyroid carcinoma, diagnosed at this Center or another Center from 01/01/1995 onward.
Main reasons for not taking part
- Follow up lasting less than 3 months
- Incomplete or missing clinical data that may affect the correct assessment of the patient
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age older than 18 years at the time of diagnosis
- Patients with thyroid pathology (hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodule, and thyroid carcinoma) in whom the diagnosis was made in our Center or another Center from 01/01/1995 until the approval of this study (retrospective phase) or from the time of approval of this study to the next 10 years (prospective phase)
- Obtaining informed consent
Who cannot take part
- Follow up lasting less than 3 months
- Incomplete or missing clinical data that may affect the correct assessment of the patient
Where in Italy
- IRCCS Azienda Ospedaliero-Universitaria di BolognaBologna, ItalyContact: Uberto Pagotto, MDTaking people
About the trial
What the trial wants to find out
Observational single-center prospective and retrospective, nonpharmacological, spontaneous cohort study.
The 2 groups in the trial
- Retrospective Group
The retrospective phase will involve about 2850 patients of whom: * 500 with hypothyroidism; * 500 suffering from hyperthyroidism/thyrotoxicosis; * 1000 affe8ed with benign thyroid nodule; * 850 suffering from thyroid carcinoma.
- Prospective Group
In the prospective phase, on the other hand, about 3000 patients will be sequentially enrolled, including: * 60/year with hypothyroidism; * 60/year suffering from hyperthyroidism/thyrotoxicosis; * 100/year suffering from benign thyroid nodule; * 80/year suffering from thyroid carcinoma.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
- Plain-language title
- Studies different diagnostic and treatment approaches for thyroid conditions in adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 17 January 2025